Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 1144-1152, 2007. First published April 19, 2007; 10.1373/clinchem.2006.084863
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.084863v1
53/6/1144    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corella, D.
Right arrow Articles by Ordovas, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corella, D.
Right arrow Articles by Ordovas, J. M.
Related Collections
Right arrow Nutrition
(Clinical Chemistry. 2007;53:1144-1152.)
© 2007 American Association for Clinical Chemistry, Inc.


Nutrition

The –256T>C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study

Dolores Corella1,2, Donna K. Arnett3, Michael Y. Tsai4, Edmond K. Kabagambe3, James M. Peacock5, James E. Hixson6, Robert J. Straka7, Michael Province8, Chao-Qiang Lai1, Laurence D. Parnell1, Ingrid Borecki8 and Jose M. Ordovas1,a

1 Nutrition and Genomics Laboratory, Jean Mayer-US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA.
2 Genetic and Molecular Epidemiology Unit and CIBER Fisiopatología de la Obesidad y Nutrición, School of Medicine, University of Valencia, Valencia, Spain.
3 Department of Epidemiology, School of Public Health, and Clinical Nutrition Research Center, University of Alabama at Birmingham, AL.
4 Laboratory of Medicine and Pathology, University of Minnesota, Minneapolis, MN.
5 Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, MN.
6 Human Genetics Center, University of Texas Health Science Center, Houston, TX.
7 Experimental and Clinical Pharmacology Department, College of Pharmacy, University of Minnesota, Minneapolis, MN.
8 Division of Biostatistics, Washington University School of Medicine, St. Louis, MO.

aAddress correspondence to this author at: Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St., Boston, MA 02111-1524. Fax 617-556-3211; e-mail jose.ordovas{at}tufts.edu.

Background: Apolipoprotein A-II (APOA2) plays an ambiguous role in lipid metabolism, obesity, and atherosclerosis.

Methods: We studied the association between a functional APOA2 promoter polymorphism (–265T>C) and plasma lipids (fasting and postprandial), anthropometric variables, and food intake in 514 men and 564 women who participated in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study. We obtained fasting and postprandial (after consuming a high-fat meal) measures. We measured lipoprotein particle concentrations by proton nuclear magnetic resonance spectroscopy and estimated dietary intake by use of a validated questionnaire.

Results: We observed recessive effects for this polymorphism that were homogeneous by sex. Individuals homozygous for the –265C allele had statistically higher body mass index (BMI) than did carriers of the T allele. Consistently, after multivariate adjustment, the odds ratio for obesity in CC individuals compared with T allele carriers was 1.70 (95% CI 1.02–2.80, P = 0.039). Interestingly, total energy intake in CC individuals was statistically higher [mean (SE) 9371 (497) vs 8456 (413) kJ/d, P = 0.005] than in T allele carriers. Likewise, total fat and protein intakes (expressed in grams per day) were statistically higher in CC individuals (P = 0.002 and P = 0.005, respectively). After adjustment for energy, percentage of carbohydrate intake was statistically lower in CC individuals. These associations remained statistically significant even after adjustment for BMI. We found no associations with fasting lipids and only some associations with HDL subfraction distribution in the postprandial state.

Conclusions: The –265T>C polymorphism is consistently associated with food consumption and obesity, suggesting a new role for APOA2 in regulating dietary intake.




The following articles in journals at HighWire Press have cited this article:


Home page
Diabetes CareHome page
J. Shen, D. K. Arnett, L. D. Parnell, J. M. Peacock, C.-Q. Lai, J. E. Hixson, M. Y. Tsai, M. A. Province, R. J. Straka, and J. M. Ordovas
Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response: The GOLDN Study
Diabetes Care, May 1, 2008; 31(5): 910 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. Castellani, C. N. Nguyen, S. Charugundla, M. M. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. J. Lusis
Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance
J. Biol. Chem., April 25, 2008; 283(17): 11633 - 11644.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. K. Kabagambe, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett
Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study
Clin. Chem., January 1, 2008; 54(1): 154 - 162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.